Lowe Wealth Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15
Closed 299
2020
Q4
$0 Hold
15
﹤0.01% 291
2020
Q3
$0 Hold
15
﹤0.01% 296
2020
Q2
$0 Hold
15
﹤0.01% 335
2020
Q1
$0 Hold
15
﹤0.01% 354
2019
Q4
$0 Buy
+15
New +$39 ﹤0.01% 332

Other funds holding BMY.RT

Lowe Wealth Advisors's BMY.RT Position: Q1 2021 in Review

Lowe Wealth Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15 shares.

Lowe Wealth Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Lowe Wealth Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Lowe Wealth Advisors sold 15 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Lowe Wealth Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Lowe Wealth Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Lowe Wealth Advisors's 13F filing for Q1 2021, filed 6 Apr 2021.